VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CTVA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CTVACorteva, Inc.
$76.87$51.4B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCTVABalance Sheet

Corteva, Inc. (CTVA) Balance Sheet

9Y historyFree accessUpdated daily

Corteva's balance sheet remains robust with a D/E ratio of 0.19 and total debt of $4.9B, though the 131% surge in PPE to $9.7B in Q2 2026 from $4.2B in Q1 2026 warrants further investigation.

CTVA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets16.36B17.34B15.1B16.26B16.8B15.55B14.77B13.52B22.97B23.05B
Cash & Short-Term Investments2.37B4.53B3.17B2.74B3.31B4.54B3.79B1.77B2.27B8.76B
Cash Only2.37B4.52B3.11B2.64B3.19B4.46B3.53B1.76B2.27B7.81B
Short-Term Investments09M63M98M124M86M269M5M5M952M
Accounts Receivable8.7B6.37B5.68B5.49B5.7B4.81B4.93B5.53B5.26B5.24B
Days Sales Outstanding163.8133.64122.53116.28119.21112.17126.47145.73134.38134.29
Inventory4.44B5.67B5.43B6.9B6.81B5.18B4.88B5.03B5.31B8.63B
Days Inventory Outstanding204.94210.72208.07253.84238.22205.07209.47214.19194.83375.04
Other Current Assets853M767M820M1.13B968M1.01B1.17B1.19B10.13B423M
Total Non-Current Assets25.29B25.51B25.73B26.74B25.82B26.8B27.88B28.88B85.71B89.91B
Property, Plant & Equipment9.74B4.22B4.1B4.29B4.25B4.33B4.4B4.55B4.54B12.44B
Fixed Asset Turnover3.19x4.12x4.12x4.02x4.10x3.62x3.23x3.05x3.14x1.15x
Goodwill10.44B10.46B10.41B10.61B9.96B10.11B10.27B10.23B10.19B45.59B
Intangible Assets8.01B8.3B8.88B9.63B9.34B10.04B10.75B11.42B12.05B0
Long-Term Investments716M160M134M115M102M76M66M66M138M1.59B
Other Non-Current Assets-3.38B2.04B1.81B1.52B1.69B1.8B1.94B2.33B58.48B29.81B
Total Assets41.64B42.84B40.83B43B42.62B42.34B42.65B42.4B108.68B112.96B
Asset Turnover0.42x0.41x0.41x0.40x0.41x0.37x0.33x0.33x0.13x0.13x
Asset Growth %6.77%4.95%-5.05%0.89%0.65%-0.72%0.59%-60.99%-3.79%-
Total Current Liabilities10.79B12.13B10.39B10.41B10.74B9.56B8.55B8.24B13.31B12.14B
Accounts Payable3.96B4.4B4.04B4.28B4.89B4.13B3.62B3.7B3.8B4.83B
Days Payables Outstanding167.75163.54154.71157.48171.2163.34155.1157.58139.35209.87
Short-Term Debt3.19B894M750M197M23M17M3M3M2.13B2.78B
Deferred Revenue (Current)7.22B3.58B3.29B3.41B3.39B3.2B2.66B2.58B2.21B2.01B
Other Current Liabilities2.95B00000232M381M3.17B2.52B
Current Ratio1.52x1.43x1.45x1.56x1.56x1.63x1.73x1.64x1.73x1.90x
Quick Ratio1.10x0.96x0.93x0.90x0.93x1.08x1.16x1.03x1.33x1.19x
Cash Conversion Cycle200.98180.82175.89212.65186.23153.9180.83202.34189.86299.45
Total Non-Current Liabilities5.45B6.33B6.41B7.31B6.33B7.16B9.04B9.6B20.22B25.89B
Long-Term Debt1.68B1.69B1.95B2.29B1.28B1.1B1.1B115M5.72B10.29B
Capital Lease Obligations00002M3M395M5M67M4M
Deferred Tax Liabilities1.43B251M478M899M1.12B1.22B893M920M05.84B
Other Non-Current Liabilities3.26B4.4B3.98B4.12B3.93B4.84B6.14B8.56B12.81B9.71B
Total Liabilities16.24B18.46B16.8B17.72B17.08B16.72B17.59B17.84B33.53B38.03B
Total Debt4.88B2.58B2.7B2.49B1.31B1.12B1.11B127M7.94B13.07B
Net Debt2.51B-1.94B-403M-155M-1.88B-3.34B-2.42B-1.64B5.67B5.26B
Debt / Equity0.19x0.11x0.11x0.10x0.05x0.04x0.04x0.01x0.11x0.17x
Debt / EBITDA1.15x0.68x0.81x0.75x0.41x0.44x0.55x0.06x3.39x28.54x
Net Debt / EBITDA0.59x-0.51x-0.12x-0.05x-0.60x-1.30x-1.20x-0.75x2.42x11.49x
Interest Coverage11.43x10.38x6.47x5.69x19.05x79.20x16.00x-1.32x-19.20x-4.05x
Total Equity25.4B24.39B24.03B25.28B25.54B25.62B25.06B24.55B75.15B74.93B
Equity Growth %0.87%1.48%-4.94%-1.03%-0.32%2.23%2.07%-67.33%0.29%-
Book Value per Share37.8236.2334.5335.5135.2534.5533.3632.76100.2899.99
Total Shareholders' Equity25.16B24.14B23.79B25.04B25.3B25.38B24.82B24.31B74.66B74.76B
Common Stock7M7M7M7M7M7M7M7M00
Retained Earnings1.22B-67M55M-41M250M524M0-425M0175M
Treasury Stock0000000000
Accumulated OCI-2.97B-2.8B-3.47B-2.68B-2.81B-2.9B-2.89B-3.27B74.66B-381M
Minority Interest244M242M241M242M239M239M239M246M493M172M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Commodity price softening

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Seasonal Swings Mask Stable Core

Total assets oscillated between $40.8B and $43.6B over ten quarters, with equity hovering near $25B, indicating a stable balance sheet despite seasonal working capital swings. According to quarterly filings, retained earnings turned positive in Q2 2026 after a Q4 2025 deficit.

The balance sheet appears to be in a steady state, with total assets fluctuating within a narrow band and equity consistently around $24-26B. The shift in retained earnings from -$67M in Q4 2025 to $1.2B in Q2 2026 suggests improved profitability, though the seasonal pattern of working capital drives most of the quarterly volatility. This stability, combined with a low debt-to-equity ratio, implies a resilient financial position that can weather commodity price cycles.

Low Leverage Provides Strategic Flexibility

Total debt ranged from $2.6B to $5.7B, with D/E peaking at 0.23 in Q3 2024 and falling to 0.11 in Q4 2025. As reported in financial statements, this leverage is modest compared to peers like FMC (D/E 2.00), suggesting ample borrowing capacity.

Corteva's debt levels are conservative, with a D/E ratio consistently below 0.25, indicating that the company is not reliant on debt to fund operations. The fluctuation in total debt, from $2.6B to $5.7B, likely reflects seasonal working capital needs and short-term borrowings, rather than strategic leverage. This low leverage provides financial flexibility for potential M&A or share repurchases, and reduces refinancing risk, especially in a rising rate environment.

Intangibles Dominate Asset Base

Goodwill and intangibles remained stable at approximately $10.4-10.6B, representing about 25% of total assets, while PPE net jumped to $9.7B in Q2 2026 from $4.2B in prior quarters. Based on reported figures, this suggests a significant asset reclassification or acquisition.

The asset mix is heavily weighted toward intangibles, with goodwill alone exceeding $10B, reflecting the company's historical acquisitions and the value placed on its germplasm and trait portfolio. The sudden increase in PPE net in Q2 2026, from $4.2B to $9.7B, is notable and may indicate a reclassification of assets or a major capital investment, though the cash flow statement shows low capex. Investors should monitor whether this PPE increase signals a shift toward more asset-intensive operations or is a one-time adjustment.

Retained Earnings Rebound Signals Strength

Equity remained stable near $25B, but retained earnings swung from -$67M in Q4 2025 to $1.2B in Q2 2026, reflecting strong quarterly profitability. According to recent SEC filings, this recovery suggests improved earnings retention despite ongoing share repurchases.

The equity base is solid, with total equity consistently above $23B, and the recent positive retained earnings indicate that the company is generating sufficient profits to build its equity cushion. The stability of equity despite share repurchases and dividends suggests that earnings are being retained to support growth. However, the volatility in retained earnings, including a deficit in Q4 2025, highlights the seasonal nature of the business and the potential for earnings swings.

Adequate Liquidity with Seasonal Cash Build

Current ratio ranged from 1.43 to 1.72, with cash peaking at $4.5B in Q4 2025 and averaging around $2.4B. As reported in financial statements, this provides a buffer against seasonal working capital needs, though it is lower than peers like CF Industries (3.37).

Corteva maintains a current ratio above 1.4, indicating sufficient short-term assets to cover liabilities, but the ratio is not exceptionally high, reflecting the efficient management of working capital. The cash balance fluctuates significantly, with a peak in Q4 2025 likely due to seasonal collections, and a trough in Q1 2024. This liquidity is adequate for operational needs, but the company may need to rely on credit lines during peak planting season, as evidenced by the higher debt levels in Q3 2024.

PPE Jump Raises Questions

PPE net surged to $9.7B in Q2 2026 from $4.2B in Q1 2026, a 131% increase, while cash flow statements show minimal capex. Based on reported figures, this discrepancy warrants investigation into potential asset reclassification or acquisition.

The sudden doubling of net PPE in Q2 2026 is a non-obvious distortion that could mislead analysts. Given that capital expenditures have been consistently low, this increase may indicate a reclassification of assets from other categories, a significant acquisition not fully captured in cash flow, or an accounting adjustment. Investors should scrutinize the footnotes to understand the nature of this change, as it could affect depreciation expenses and future asset turnover ratios.

CTVA — Frequently Asked Questions

Quick answers to the most common questions about buying CTVA stock.

What are the total assets of Corteva, Inc. (CTVA)?

As of 2025, Corteva, Inc. (CTVA) had total assets of $42.84B including $17.34B in current assets.

How much debt does Corteva, Inc. (CTVA) have?

Corteva, Inc. (CTVA) carries total debt of $2.58B, offset by $4.53B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Corteva, Inc.?

Corteva, Inc. (CTVA) has total shareholders' equity (book value) of $24.14B ($36.23 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Corteva, Inc.'s current ratio and liquidity?

Corteva, Inc. (CTVA) reported a current ratio of 1.43x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.